1
|
Kong L, Zhao Y, Wang Y, Chang X, Cui L, Gu G, Ma Z, Lu Q, Zhou L, Ding L, Wang Z, Shao Y, Tang H, Zhang C, Hui F, Mei X, Xin J, Huo J, Sun S, Zhu S, Yao C, Du G, Cheng M, Kang J. Efficacy and safety of tratinterol hydrochloride tablets in bronchial asthma: a randomized double-blind and multicenter clinical trial. J Asthma 2019; 58:85-92. [PMID: 31514546 DOI: 10.1080/02770903.2019.1663427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
PURPOSE The aim of this study was to investigate the efficacy and safety of tratinterol hydrochloride in bronchial asthma (BA) treatment. METHODS Patients enrolled in this study were distributed randomly into a treatment group (tratinterol hydrochloride) and an active control group (procaterol hydrochloride) and were treated for 2 weeks after running-in. The end points were changes in pulmonary function and clinical symptoms after administration. Safety indices were physical examinations, laboratory testing and spontaneous reporting. FINDINGS We enrolled 732 subjects, -365 in the treatment group and 367 in the active control group. Forced expiratory volume (FEV1), significantly increased in both group after treatment (P < 0.05). Least-squares (LS) means were -0.03/in the full-analysis set (FAS) and -0.02 in the per-protocol set (PPS) set, and 95% confidence intervals (CIs) for these sets were -0.09 to 0.03 and -0.08 to 0.04, respectively. Forced expiratory volume (FVC), morning peak expiratory flow (PEF) and asthma scores were significantly different with pretreatment (P < 0.05). There was no difference in asymptomatic days or frequency of relief medicine use (P > 0.05). No serious adverse events occurred. IMPLICATIONS Tratinterol hydrochloride was effective, safe and not inferior to procaterol hydrochloride in treating BA.
Collapse
Affiliation(s)
- Lingfei Kong
- The Institute Respiratory Disease, The First Hospital of China Medical University, Shenyang, China
| | | | | | - Xiaoyue Chang
- The Center Hospital of Baotou, Baotou, Neimenggu, China
| | - Liying Cui
- The Affiliated Hospital of Inner Mongolia Medical University, Huhehaote, Inner Mongolia, China
| | - Guozhong Gu
- Daqing General Hospital Group Oilfield General Hospital, Daqing, Heilongjiang, China
| | - Zhuang Ma
- The General Hospital of Shenyang Military, Shenyang, Liaoning, China
| | - Qiang Lu
- People's Hospital of Tianjin, Tianjin, China
| | - Liying Zhou
- Lanzhou University Second Hospital, Lanzhou, Gansu, China
| | | | - Zhenshan Wang
- The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
| | - Yuxia Shao
- The Second Affiliated Hospital of Harbin Medical University, HarBin, Heilongjiang, China
| | - Huaping Tang
- Qingdao Municipal Hospital, Qingdao, Shandong, China
| | - Chunyu Zhang
- The Center Hospital of Siping, Siping, Jilin, China
| | - Fuxin Hui
- Wu Xi People's Hospital, Wuxi, Jiangsu, China
| | | | - Jianbao Xin
- Xiehe Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Jianmin Huo
- The First Affiliated Hospital of HarBin Medical University, HarBin, Heilongjiang, China
| | - Shenghua Sun
- Respiratory Department, The Third Xiangya Hospital, Changsha, Hunan, China
| | - Sainan Zhu
- The Department of Health Statistics, Peking University, Beijing, China
| | - Chen Yao
- The Department of Health Statistics, Peking University, Beijing, China
| | - Guijie Du
- Shenyang Pharmaceutical University, Shenyang, Liaoning, China
| | - Maosheng Cheng
- The Company of Jinzhou Jiutai Pharmaceutical Co., Ltd, Jinzhou, Liaoning, China
| | - Jian Kang
- Respiratory Department, The Institute Respiratory Disease, The First Hospital of China Medical University, Shenyang, China
| |
Collapse
|
2
|
Qin F, Yin B, Wang L, Li K, Li F, Xiong Z. Quantification of trantinterol, its two metabolites and their primary conjugated metabolites in human plasma by ultra-high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study. J Pharm Biomed Anal 2016; 117:413-8. [PMID: 26448609 DOI: 10.1016/j.jpba.2015.09.020] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2015] [Revised: 09/16/2015] [Accepted: 09/16/2015] [Indexed: 11/16/2022]
Abstract
A highly rapid, selective and sensitive ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed to simultaneously determine trantinterol, its major phase-I metabolites and their primary conjugated metabolites in human plasma. Waters Oasis HLB C18 solid phase extraction cartridges were used in the sample preparation. The separation was carried out on an ACQUITY UPLC™ BEH C18 column with methanol/0.2% formic acid (30:70, v/v) as the mobile phase at a flow rate of 0.25 mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer in selective reaction monitoring (SRM) mode with the use of an electrospray ionization (ESI) source. The linear calibration curves for trantinterol, tert-butyl hydroxylated trantinterol (tert-OH-trantinterol) and 1-carbonyl trantinterol (trantinterol-COOH) were obtained in the concentration ranges of 0.200-250, 0.108-4.00 and 0.0840-5.02 ng/mL, respectively (r(2)≥0.99). The intra- and inter-day precision (relative standard deviation, RSD) values were less than 13%, and the accuracy (relative error, RE) was within ±9.9%, as determined from quality control (QC) samples for the analytes. The concentrations of conjugated forms of trantinterol and tert-OH- trantinterol in plasma were determined using selective enzyme hydrolysis. The method described herein was fully validated and successfully applied for the pharmacokinetic study of trantinterol in healthy volunteers after oral administration.
Collapse
Affiliation(s)
- Feng Qin
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Bincan Yin
- College of Medical Informatics, China Medical University, Shenyang 110013, PR China
| | - Lijuan Wang
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Kunjie Li
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Famei Li
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Zhili Xiong
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China.
| |
Collapse
|
3
|
Qin F, Wang L, Li K, Xiong Z, Li F. Simultaneous quantification of trantinterol and its metabolites in human urine by ultra performance liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 997:64-9. [DOI: 10.1016/j.jchromb.2015.05.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Revised: 05/01/2015] [Accepted: 05/09/2015] [Indexed: 10/23/2022]
|
4
|
Wang Y, Qin F, Xiong Z, Fu X, Ma C. An LC-MS/MS method for simultaneous determination of trantinterol and its major metabolite in rat plasma and its application to a comparative pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 1000:163-8. [PMID: 26245359 DOI: 10.1016/j.jchromb.2015.07.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2015] [Revised: 07/06/2015] [Accepted: 07/08/2015] [Indexed: 11/26/2022]
Abstract
Trantinterol is a novel β2-adrenoceptor agonist, currently undergoing clinical trials for the treatment of asthma. We developed and validated an liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of trantinterol and its major metabolite, 1-carbonyl trantinterol (SPFFCOOH), in rat plasma. Aliquots (100μL) of heparinized plasma samples were processed by protein precipitation with acetonitrile. Chromatographic separation used an Acquity UPLC BEH C18 column (2.1mm×50mm, 1.7μm) and acetonitrile-0.1% formic acid (20:80, v/v) as mobile phase, at a flow rate of 0.25mL/min. The detection was performed on a triple-quadrupole tandem mass spectrometer with multiple-reaction monitoring (MRM) mode via electrospray ionization (ESI) source. The precursor-to-product ion transitions m/z 310.9→m/z 237.9 for trantinterol, m/z 324.9→m/z 251.9 for SPFFCOOH and m/z 368.0→m/z 294.0 for bambuterol (internal standard, IS) were used for quantification. The calibration curves were obtained in the concentration of 0.25-100ng/mL for both trantinterol and SPFFCOOH. The intra- and inter-day precision (relative standard deviations, RSD) values were below 15% and accuracy (relative error, RE) was from -4.3% to 6.6% at all quality control (QC) levels. The method was successfully applied to compare the pharmacokinetics of trantinterol and SPFFCOOH in male and female Wistar rats after a single oral administration of trantinterol.
Collapse
Affiliation(s)
- Yanjuan Wang
- School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Feng Qin
- School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Zhili Xiong
- School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, PR China
| | - Xiaohuan Fu
- Jiangsu Kanion Pharmaceutical Co., Ltd, 58 Haichang South Road, Xinpu District, Lianyungang 222001, PR China
| | - Chao Ma
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
| |
Collapse
|
5
|
Qin F, Wang Y, Wang L, Zhao L, Pan L, Cheng M, Li F. Determination of trantinterol enantiomers in human plasma by high-performance liquid chromatography - tandem mass spectrometry using vancomycin chiral stationary phase and solid phase extraction and stereoselective pharmacokinetic application. Chirality 2015; 27:327-31. [PMID: 25782043 DOI: 10.1002/chir.22432] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2014] [Revised: 12/19/2014] [Accepted: 01/13/2015] [Indexed: 01/16/2023]
Abstract
A sensitive and enantioselective vancomycin chiral stationary phase high-performance liquid chromatography-tandem mass spectrometry method was developed for the determination of trantinterol enantiomers in human plasma. Baseline resolution was achieved using the vancomycin chiral stationary phase known as Chirobiotic V with polar ionic mobile phase consisting of acetonitrile-methanol (60:40, v/v) containing 0.01% ammonia and 0.02% acetic acid at a flow rate of 1.0 mL/min. Waters Oasis HLB C18 solid phase extraction cartridges were used in the sample preparation of trantinterol samples from plasma. The detection was performed on a triple-quadrupole tandem mass spectrometer by multiple reaction monitoring mode via electrospray ionization. The calibration curve was linear in a concentration range from 0.0606 to 30.3 ng/mL in plasma, with the lower limit of quantification of 0.0606 ng/mL. The intra- and interday precision (relative standard deviation) values were within 9.7% and the accuracy (relative error) was from -6.6 to 7.2% at all quality control levels. The method was successfully applied to a study of stereoselective pharmacokinetics in human.
Collapse
Affiliation(s)
- Feng Qin
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China
| | | | | | | | | | | | | |
Collapse
|
6
|
Huang J, Lu Y, Wan Q, Zhang M, Pei Q, Zhang M, Liu G, Yang G. Simultaneous Determination of Trantinterol and One of Its Major Metabolites, 1-Carbonyl Trantinterol, in Human Plasma by LC-MS-MS. J Chromatogr Sci 2015; 53:1303-9. [PMID: 25689985 DOI: 10.1093/chromsci/bmv009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2014] [Indexed: 11/14/2022]
Abstract
A highly selective and sensitive liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous determination of trantinterol and one of its major metabolites, 1-carbonyl trantinterol, in human plasma. An Oasis MCX 96-well solid-phase extraction cartridge and a SeQuantTM ZIC(®)-HILIC LC column were used for sample preparation and chromatographic separation, respectively. The analytes were monitored by a QTrap 5500 mass spectrometer with positive electrospray ionization. Multiple reaction monitoring was used for quantification using the precursor to product ion pairs of m/z 311.1 → 237.9 (trantinterol), m/z 325.1 → 251.9 (1-carbonyl trantinterol) and m/z 368.4 → 294.0 (bambuterol as internal standard). The assay had a calibration range from 0.2 to 50 pg/mL and a lower limit of quantification of 0.2 pg/mL for both trantinterol and 1-carbonyl trantinterol. The inter-day and intra-day precisions were <12.0% and the accuracies were within the range of 87.1-111%. The mean recovery ranged from 82.0 to 97.7% and internal standard normalized matrix effect from 0.813 to 0.899. The analytes were stable under all tested conditions. This validated method was successfully applied to a pilot pharmacokinetic study in healthy subjects administered a single 50 μg oral dose.
Collapse
Affiliation(s)
- Jie Huang
- Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China
| | - Youli Lu
- Drug Clinical Research Centre of Shanghai Xuhui Central Hospital, Shanghai 200031, China
| | - Qian Wan
- Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China
| | - Meiwei Zhang
- Drug Clinical Research Centre of Shanghai Xuhui Central Hospital, Shanghai 200031, China
| | - Qi Pei
- Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China
| | - Mengqi Zhang
- Drug Clinical Research Centre of Shanghai Xuhui Central Hospital, Shanghai 200031, China
| | - Gangyi Liu
- Drug Clinical Research Centre of Shanghai Xuhui Central Hospital, Shanghai 200031, China
| | - Guoping Yang
- Center of Clinical Pharmacology, Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China
| |
Collapse
|
7
|
Simultaneous determination of trantinterol and its metabolites in rat urine and feces by liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 934:89-96. [DOI: 10.1016/j.jchromb.2013.06.033] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2013] [Revised: 06/13/2013] [Accepted: 06/29/2013] [Indexed: 11/24/2022]
|
8
|
Jing L, Li K, Qin F, Wang X, Pan L, Wang Y, Cheng M, Li F. Determination of L-trantinterol in rat plasma by using chiral liquid chromatography-tandem mass spectrometry. J Sep Sci 2012; 35:2678-84. [DOI: 10.1002/jssc.201200332] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2012] [Revised: 06/05/2012] [Accepted: 06/12/2012] [Indexed: 11/10/2022]
Affiliation(s)
- Lijuan Jing
- School of Pharmacy; Shenyang Pharmaceutical University; Shenyang China
| | - Kunjie Li
- School of Pharmacy; Shenyang Pharmaceutical University; Shenyang China
| | - Fen Qin
- School of Pharmacy; Shenyang Pharmaceutical University; Shenyang China
| | - Xintao Wang
- School of Pharmacy; Shenyang Pharmaceutical University; Shenyang China
| | - Li Pan
- School of Pharmaceutical Engineering; Shenyang Pharmaceutical University; Shenyang China
| | - Yanjuan Wang
- School of Pharmacy; Shenyang Pharmaceutical University; Shenyang China
| | - Maosheng Cheng
- School of Pharmaceutical Engineering; Shenyang Pharmaceutical University; Shenyang China
| | - Famei Li
- School of Pharmacy; Shenyang Pharmaceutical University; Shenyang China
| |
Collapse
|
9
|
Lin QB, Zhao XT, Song H, Pan YL. Immunoaffinity chromatography purification and ultra-high-performance liquid chromatography-tandem mass spectrometry determination of four β-agonists in beef. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2012; 29:935-41. [DOI: 10.1080/19440049.2012.666679] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Q.-B. Lin
- a Institute of Applied Chemistry, Shanxi University , Taiyuan 030006 , China
| | - X.-T. Zhao
- a Institute of Applied Chemistry, Shanxi University , Taiyuan 030006 , China
| | - H. Song
- b Shanxi Border Inspection and Quarantine Bureau , Taiyuan 030024 , China
| | - Y.-L. Pan
- b Shanxi Border Inspection and Quarantine Bureau , Taiyuan 030024 , China
| |
Collapse
|
10
|
Assessment of a novel β2-adrenoceptor agonist, trantinterol, for interference with human liver cytochrome P450 enzymes activities. Toxicol In Vitro 2011; 25:1033-8. [DOI: 10.1016/j.tiv.2011.03.024] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2010] [Revised: 03/09/2011] [Accepted: 03/30/2011] [Indexed: 01/23/2023]
|
11
|
Wang Y, Lu X, Jiang K, Xiong Z, Cheng M, Li F. Liquid chromatography-mass spectrometry for analysis of a novel beta(2)-adrenoceptor agonist trantinterol and its metabolites in beagle dog urine. Biomed Chromatogr 2009; 24:274-80. [PMID: 19609869 DOI: 10.1002/bmc.1284] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
A liquid chromatography-tandem mass spectrometry method was developed for the identification of metabolites of trantinterol, a novel beta(2)-adrenoceptor agonist, in beagle dog urine. The separation of metabolites was performed on a reversed-phase C(8) column using 0.1% formic acid in water and methanol (70 : 30, v/v) as the mobile phase. The structural information and elemental information of metabolites were acquired by an electrospray ionization tandem mass spectrometer and a quadrupole time-of-flight mass spectrometer, respectively. A total of 13 metabolites were detected and characterized on the basis of their tandem MS/MS fragmentation patterns. The accurate masses of nine metabolites were determined and two metabolites were further confirmed by comparing with reference standards. The metabolic pathways of trantinterol in beagle dog are proposed.
Collapse
Affiliation(s)
- Yanjuan Wang
- Department of Analytical Chemistry, Shenyang Pharmaceutical University, People's Republic of China
| | | | | | | | | | | |
Collapse
|